Literature DB >> 2423804

The clinical pharmacology of indoramin.

R G Shanks.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2423804     DOI: 10.1097/00005344-198600082-00003

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


× No keyword cloud information.
  3 in total

1.  Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.

Authors:  A P Good; D V Unverferth; C V Leier
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

2.  Anti-arrhythmic properties of the alpha-adrenoceptor blocking drug indoramin.

Authors:  M A James; J V Jones
Journal:  Br J Clin Pharmacol       Date:  1991-09       Impact factor: 4.335

Review 3.  Clinical pharmacokinetics of vasodilators. Part II.

Authors:  R Kirsten; K Nelson; D Kirsten; B Heintz
Journal:  Clin Pharmacokinet       Date:  1998-07       Impact factor: 6.447

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.